3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Leukemia, Myeloid, Acute
4
Recurrence
2
Paraproteinemias
2
Papillomavirus Infections
2
Immunoglobulin Light-chain Amyloidosis
2
Colorectal Neoplasms
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thyroid Nodule
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Postoperative Complications
1
Pneumonia
1
Pancreatic Neoplasms
1
Obesity
1
Neoplasms, Plasma Cell
1
Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Mantle-Cell
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
Locally Advanced Breast Cancer
1
Intermittent Fasting
1
Hypothyroidism
1
Hyperthyroidism
1
Interventions
Cisplatin
274
pembrolizumab
229
Radiotherapy
166
Cetuximab
163
Carboplatin
122
Docetaxel
109
Paclitaxel
94
Fluorouracil
94
Nivolumab
84
Radiotherapy, Intensity-Modulated
78
Magnetic Resonance Spectroscopy
39
durvalumab
35
Radiation
32
Surgical Procedures, Operative
31
Drug Therapy
30
Radiosurgery
25
Erlotinib Hydrochloride
25
Biopsy
25
Albumin-Bound Paclitaxel
24
130-nm albumin-bound paclitaxel
24
Taxes
23
Platinum
22
Specimen Handling
21
tislelizumab
20
1,2-diaminocyclohexaneplatinum II citrate
20
Cyclophosphamide
19
Capecitabine
19
tremelimumab
18
Ipilimumab
18
Gemcitabine
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Squamous Cell Carcinoma of Head and Neck
×
Clinical Protocols
×
Clear all
NCT06130007
2023-11-13
B2023-153
Sun Yat-sen University
Phase 2
Unknown
48 enrolled